DaVita Inc. (DVA) Given New $100.00 Price Target by UBS AG (UBS) Analysts. - NewsyStocks.com PDF Print
NewsyStocks.com
DaVita Inc. (DaVita) is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2009, the Company operated or provided administrative

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.